University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments Subchapter
Status: Green Selsun® shampoo application 13.9
Status: Red Semaglutide (Wegovy®)

The use of semaglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place.

Prescribe by brand (Wegovy®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.

The Wegovy® brand of semaglutide is not commercially available yet.

6.1
Status: Green Semaglutide solution for injection (Ozempic®) 6.1
Status: Green Semaglutide tablets (Rybelsus®) (GLP1s should all be prescribed by brand name) 6.1
Status: Green Senna syrup 1.6
Status: Green Senna tablets 1.6
Status: Green Sertraline tablets 4.3
Status: Amber Sevelamer tablets

Specialist recommendation.

9.5
Status: Red Sevoflurane 15.1
Status: Red Sildenafil injection

Hospital use only. NHS England commissioned.

2.5

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top